For people living with HIV/AIDS, this means providing greater access to care and educational programs, as well as supporting research efforts and developing lasting partnerships that will help battle the disease. Explore how Merck is helping.
Collaboration is a hallmark of the progress made against HIV. See how Merck's commitment to improving patient access is helping in the global fight.
1.2 million people in the U.S. are living with HIV infection, with 50,000 new infections each year.
For nearly 25 years, Merck has supported HIV/AIDS research, care access and partnerships around the world. Watch the video.
The Merck Company Foundation is committing $3 million to help connect HIV-positive people in three U.S. cities to effective, comprehensive healthcare. Learn more about the HIV Care Collaborative.
We are committed to the long-term battle against this disease. Learn more about our global partnerships.
The China-MSD HIV/AIDS Partnership (C-MAP) is an award-winning program to increase awareness of HIV/AIDS, and strengthen prevention, treatment and support for those affected in the country. Learn more about C-MAP.
Of the estimated 15 million people living with HIV in low- and middle income countries, 6.6 million have access to treatment.